A431 cells - OmicsDI

Show results for

Unknown (422)
Genomics (49)
Proteomics (39)
Transcriptomics (38)
Other (1)
Multiomics (1)

Organisms

Homo sapiens (40)
Bartonella quintana JK 31 (32)
Bombyx mori (32)
Onchocerca volvulus (32)
Klebsiella pneumoniae (32)
Musca domestica (32)
Brugia malayi (32)
Schizosaccharomyces pombe (32)
Cnidaria (32)
Streptomyces coelicolor A3(2) (32)
Sus scrofa (32)
Human immunodeficiency virus 1 (32)
Oryza sativa Indica Group (32)
Sinorhizobium meliloti BL225C (32)
Vitis (32)
Sus scrofa domesticus (32)
Ostreococcus tauri (32)
Saccharomyces cerevisiae (32)
Synechocystis sp. PCC 6803 (32)
Populus tremula x Populus alba (32)
Olavius algarvensis Gamma 1 endosymbiont (32)
Vitis vinifera (32)
Gigantopelta aegis (32)
Saccharopolyspora erythraea (32)
Staphylococcus aureus (32)
Rattus norvegicus (32)
Rattus rattus (32)
Pseudomonas aeruginosa (32)
Olavius algarvensis Delta 4 endosymbiont (32)
Fusarium sinicum (1)

Organisms

Homo sapiens (42)

Repository

ENA (47)
pride (32)
geo (24)
biostudies-arrayexpress (14)
MassIVE (4)
ExpressionAtlas (2)
jPOST (2)
GPMDB (1)
PAXDB (1)

Tissue

Cell culture (14)
Epithelial cell (12)
Skin (5)
Permanent cell line cell (4)
Skin epidermis (2)
Keratinocyte (2)
Cell suspension culture (2)
HeLa cell (2)
Testis (2)
Kidney (2)
Liver (2)
A-431 cell (1)
A-549 cell (1)
Tonsil (1)
Epithelial cell migration (1)
Squamous cell of epidermis (1)
Epidermal cell (1)
Prostate gland (1)
Placenta (1)
JURKAT cell (1)
Ovary (1)
Skeletal muscle (1)
Blood plasma (1)
Spleen (1)
Erythrocyte (1)
Lung (1)

Disease

Squamous cell carcinoma (3)
Carcinoma (2)
Cancer (2)
Epidermoid carcinoma (1)
Glioblastoma (1)
Not Available (1)
Squamous cell carcinoma of the skin (1)
Skin carcinoma (1)
Lung cancer (1)
Chronic myeloid leukemia (1)
Skin squamous cell carcinoma (1)
Malignant neoplasm of ovary (1)
Disease free (1)

Technology Type

Mass Spectrometry (32)
Shotgun proteomics (24)
Bottom-up proteomics (4)
Affinity purification coupled with mass spectrometry proteomics (4)
Gel-based experiment (2)
SWATH MS (1)
Data-independent acquisition (1)
Data-dependent acquisition (1)

Instrument Platform

Q Exactive (3)
Illumina HiSeq 2000 (2)
Illumina HiSeq 2500 (1)
Instrument (1)
LTQ Orbitrap Elite (1)

Publication Date

2018 (10)
2025 (8)
2023 (7)
2019 (7)
2020 (7)
2017 (5)
2016 (4)
2015 (4)
2008 (4)
2022 (4)
2021 (4)
2013 (3)
2026 (3)
2024 (3)
2011 (2)
2012 (1)
2009 (1)
2010 (1)
2014 (1)

UNIPROT ID/AC

I13R2_HUMAN (1)
SRR1L_HUMAN (1)
TR10A_HUMAN (1)
TMM91_HUMAN (1)
JDP2_HUMAN (1)
CCD84_HUMAN (1)
CDT1_HUMAN (1)
MYBB_HUMAN (1)
TAGAP_HUMAN (1)
EZHIP_HUMAN (1)
CENPM_HUMAN (1)
9606.ENSP00000367891 (1)
9606.ENSP00000401018 (1)
CBLC_HUMAN (1)
CCNE2_HUMAN (1)
FIZ1_HUMAN (1)
G6PT3_HUMAN (1)
5NT1B_HUMAN (1)
PTTG1_HUMAN (1)
SKA2_HUMAN (1)
TREF1_HUMAN (1)
NXNL2_HUMAN (1)
H3BLT4_HUMAN (1)
TM14B_HUMAN (1)
SIX4_HUMAN (1)
SKP2_HUMAN (1)
ZMYM1_HUMAN (1)
CLD6_HUMAN (1)
CLD9_HUMAN (1)
S45A4_HUMAN (1)

First Public Date

2025 (11)
2019 (6)
2020 (5)
2014 (5)
2018 (4)
2023 (3)
2021 (3)
2016 (3)
2026 (2)
2024 (2)
2022 (1)
2017 (1)
2015 (1)

Study type

Transcription profiling by array (10)
RNA-seq of coding RNA (4)

Release Date

2023 (45)
2022 (42)
2021 (40)
2020 (34)
2019 (31)
2018 (30)
2016 (26)
2025 (22)
2024 (22)
2014 (20)
2012 (19)
2017 (18)
2015 (17)
2013 (17)
2011 (11)
2008 (7)
2010 (7)
2009 (5)
2026 (5)
2007 (3)
2006 (3)
2005 (2)
2004 (2)
2003 (2)
2002 (2)
2000 (2)
1999 (1)
1987 (1)

Lab affiliation

University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (3)
Associate Director of Analytical Services, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA (1)
University of Bordeaux, Inserm, UMR1312, BRIC, BoRdeaux Institute of onCology, 146 Rue Léo Saignat, Bordeaux, F-33076, France. (1)
Oslo University Hospital, Oslo, Norway (1)
Southern Medical University, No. 1023-1063, Shatai South Road, Baiyun District, Guangzhou (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, the Netherlands. Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, the Netherlands (1)
Chair of Proteomics and Bioanalytics Technische Universitaet Muenchen (1)
Scientific Officer-G Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai-410210, India (1)
Scientific Officer-G Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai-410210, India (1)
Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College (1)
Dept. of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway (1)
Paul Scherrer Institute Center for Radiopharmaceutical Sciences Forschungsstrasse 111 5232 Villigen PSI Switzerland (1)
Laboratory for Functional Genome Analysis Genzentrum Ludwig-Maximilians-Universität München Feodor-Lynen-Str. 25 D-81377 München Germany (1)
Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory and Karolinska Institutet, Stockholm, Sweden (1)
University of Vienna Faculty of Chemistry Department of Analytical Chemistry (1)
Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. (1)
Washington University in Saint Louis (1)
NTU (1)
Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V., Dortmund, Germany Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, Canada. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Canada. (1)
A2 Biotherapeutics (1)
Department of Oncology-Pathology, Karolinska Institutet, and Science For Life Laboratory, Stockholm, Sweden (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, The Netherlands Netherlands Proteomics Center, Padualaan 8, Utrecht 3584 CH, The Netherlands (1)
Discovery Platform Technologies, AbbVie (1)
Dept. Oncology Pathology, Karolinska Institutet, Scilifelab, Stockholm, Sweden (1)
Stem Cells and Metabolism Research Program and Dept. of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland; (1)
1. Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia. 2. Research Centre for Extracellular Vesicles, La Trobe University, Victoria, Australia. (1)
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, United States of Americ (1)
Univ. Bordeaux, Bordeaux Proteome, Bordeaux, France (1)
Dept. Oncology Pathology, Karolinska Institutet, and Scilifelab, Stockholm, Sweden (1)
Paul Scherrer Institute Center for Radiopharmaceutical Sciences Forschungsstrasse 111 5232 Villigen PSI Switzerland (1)

Previous page
1 / 55
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 55
Next page

Sort by:

Relevance

Page size

human epidermoid carcinoma cell: Control (A431-P cells) vs. highly invasive subline (A431-III cells)

Transcriptional profiling of human epidermoid carcinoma cell comparing control A431-P cells with highly invasive subline A431-III cells No treatmentt, A431-P cells vs. A431-III cells. A431-P cells are used as a reference to invstigate A431-III cells.

ORGANISM(S): Homo sapiens

2013-06-18 | E-GEOD-47996 | biostudies-arrayexpress

Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells

A431 wild-type (wt) cancer cell line is sensitive to treatment with EGFR tyrosine kinase inhibitors (TKIs). By culturing it chronically under gefitinib, it eventually becomes resistant (A431_GR cell). We know of a few proteins involved in this mechanism of drug resistance, but a cDNA exprssion array...

ORGANISM(S): Homo sapiens

2008-04-06 | E-GEOD-10696 | biostudies-arrayexpress

RNA-seq of TCF4 silencing in A431 cells

TCF4 was silenced in cutaneous squamous cell carcinoma of A431 cells, and detected the mRNA profiles compared to the negative control and blank control.

ORGANISM(S): Homo sapiens

2019-07-06 | E-MTAB-7372 | biostudies-arrayexpress

HiRIEFII proteomics and proteogenomics of A431 cells and five histologically normal tissues

High Resolution Isoelectric Focusing (HiRIEF) LC-MS was used to analyze samples from the human A431 cell line and also samples of histologically normal tissues. The high analytical depth afforded by HiRIEF permitted proteogenomics on these two sample sets (A431 cells and normal tissues). The A431 d...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2018-10-04 | MSV000083000 | MassIVE

Impact of biomechanical stimulation in the toxicity of deoxynivalenol in A431 cells: impairment of “dynamic” cell functions

Morphology together with the capability to respond to surrounding stimuli are the key elements governing the spatial interaction of a living cell with the environment. In this respect, biomechanical stimulation can trigger significant physiological cascades that can potentially modulate or interact ...

ORGANISM(S): Homo sapiens (Human)

2018-07-31 | PXD008996 | Pride